Investor profile for Canaan Partners: typical check size, headquarters (600 Fifth Ave, New York, NY 10020), stages they lead or invest in, and links to website and social profiles. Part of the Venture Capital Tracker directory.

Canaan Partners

Multi-stage venture firm founded in 1987 with offices in New York and the Bay Area. Canaan backs fintech and healthcare companies from seed through growth — public portfolio includes LendingClub and The RealReal.

Typical check size

$1M-$10M (stage-based estimate)

Founded

1987

Headquarters

600 Fifth Ave, New York, NY 10020

AUM

N/A

Rounds they lead

Series A Series B+

Rounds they invest

Seed Series A Series B+

Portfolio companies we track

Startups in our directory that list Canaan Partners as an investor (4 total).

Related investment articles

FAQs about Canaan Partners

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

Canaan leads Series A and growth rounds and participates in seed. Our directory lists Series A and Series B+ as lead stages. The firm runs dedicated fintech and healthcare practices spanning early to later stage.
Canaan does not publicly disclose a single typical check. As a multi-stage firm, checks range from seed participations to large Series B+ rounds depending on the fund and opportunity.
Offices at 600 Fifth Ave, New York, NY, and in the San Francisco Bay Area (per canaan.com). Canaan invests in U.S. companies across both coasts with sector teams in fintech and healthcare.
Fintech and healthcare are core verticals, with additional enterprise and consumer bets. Public portfolio references include LendingClub and The RealReal. Our directory tags fintech and healthtech.
Canaan leads Series A and growth rounds in its focus sectors and selectively co-leads seed. It is an active board-level partner, not a passive follower.
In our directory: OpenArt (/startup/openart), Vedana Therapeutics (/startup/vedana-therapeutics), Forte (/startup/forte), and Forte Labs Inc. (/startup/forte-labs-inc).
Target the fintech or healthcare partner at canaan.com aligned with your stage. Warm introductions from portfolio CEOs, operators, or co-investors in those verticals are standard.
See /2026-canaan-partners-vedana-therapeutics-series-a and /2026-canaan-partners-openart-30m-series-a for recent Canaan-backed rounds in our blog.